Bitterroot Bio
About:
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
Website: https://brbio.com
Twitter/X: BitterrootBio
Top Investors: Deerfield, Google Ventures, Alexandria Venture Investments, ARCH Venture Partners, Koch Disruptive Technologies
Description:
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
Total Funding Amount:
$145M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Palo Alto, California, United States
Founded Date:
2021-01-01
Contact Email:
info(AT)brbio.com
Founders:
Irving L. Weissman, John C. Martin, Lou Lange, Nicholas Leeper
Number of Employees:
11-50
Last Funding Date:
2023-06-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai